Here are some more thoughts on the path to commercialisation for GvHD, why there aren’t any competing therapies in the same area and what it might be worth to CYP: https://hotcopper.com.au/threads/why-cynatas-gvhd-treatment-might-not-need-a-phase-two-trial-for-fda-approval.8358026/
Here are some more thoughts on the path to commercialisation for...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
16.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $37.28M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 352684 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.5¢ | 49843 | 2 |
View Market Depth
| Last trade - 10.02am 17/06/2025 (20 minute delay) ? |
| CYP (ASX) Chart |
Day chart unavailable